Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide dismutase 1 pseudogene 2 (SOD1P2) is a **pseudogene**—a genomic DNA sequence similar to that of the known functional gene *SOD1* but which is generally **non-coding** and does not produce a functional protein product[4][6]. Unlike the functional *SOD1* gene, which encodes the enzyme superoxide dismutase 1 that is important in cellular defense against oxidative stress, SOD1P2 lacks protein-coding potential and is classified as a processed or unprocessed pseudogene, depending on its genomic structure. Pseudogenes have historically been considered "genomic fossils," but recent research suggests some may have regulatory roles, often through the production of non-coding RNAs that can influence the expression of their functional gene counterparts or other genes by mechanisms such as acting as microRNA sponges or producing regulatory RNAs[6]. There is currently **no established direct biological or disease-related function** attributed specifically to SOD1P2, and it is **not considered a therapeutic target**. Unlike functional proteins, pseudogenes are not targets for approved drugs and generally do not serve as direct biomarkers or safety liabilities, though exceptions may exist in other pseudogenes when they are shown to be involved in disease through regulatory effects[4][6]. **Notes:** - SOD1P2 is distinct from the functional *SOD1* gene, which is implicated in disorders such as amyotrophic lateral sclerosis and has enzymatic antioxidant activity. - The status of SOD1P2 as a pseudogene means it is **not a receptor, enzyme, transporter, or drug target**. - Functional and disease annotations apply to *SOD1*, not to SOD1P2[1][7]. - There are no known drugs, disease associations, or mechanisms of action involving SOD1P2 as a drug target. - If information therapy or biomarker roles for this specific pseudogene become available in the future, these categories should be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide dismutase 1 pseudogene 2 (SOD1P2).